CNCanada News
Health

GLP-1 drugs are driving higher sales for Eli Lilly and Novo Nordisk

By Uday Rana

Global News - Health · 3d ago

Sales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the year to US$9.94 billion, well above analysts' expectations.

Originally published by Global News - Health.

Related News

More Health →

Restaurant Brands reports higher sales and profit, driven by Burger King’s U.S. stores

Fast-food giant’s turnaround plan for Burger King began to pay off in the quarter, while Tim Hortons’ sales growth in Canada fell flat

The Globe and Mail - Business · 2d ago

Dump truck driver charged with impaired driving after reports of swerving: OPP

A Brampton man is charged after OPP say he was driving a fully loaded gravel dump truck while impaired and nearly struck oncoming traffic in Puslinch.

Global News - Top Stories · 1d ago

Child driving car strikes woman walking dog in California, police say

Police said the driver of the vehicle was a juvenile under 10 years old, who was transported to a hospital for further medical treatment and listed in stable condition.

Global News - Top Stories · 1d ago

Sun Life posts higher profit on domestic business, strength in Asia

Company also announces retirement of board chair Scott Powers, who will be succeeded by Joseph Natale

The Globe and Mail - Business · 2d ago

← Top Stories